For the year ending 2025-12-31, INSM made $606,423K in revenue. -$1,276,775K in net income. Net profit margin of -210.54%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Product revenues, net | 606,423 | 363,707 | ||
| Cost of product revenues (excluding amortization of intangible assets) | 122,938 | 85,742 | ||
| Research and development | 771,093 | 598,367 | ||
| Selling, general and administrative | 701,167 | 461,116 | ||
| Amortization of intangible assets | 6,001 | 5,052 | ||
| Change in fair value of deferred and contingent consideration | 251,993 | 91,682 | ||
| Total operating expenses | 1,853,192 | 1,241,959 | ||
| Operating loss | -1,246,769 | -878,252 | ||
| Investment income | 60,656 | 53,307 | ||
| Interest expense | 83,795 | 84,913 | ||
| Change in fair value of interest rate swap | 0 | -236 | ||
| Other (expense) income, net | -1,841 | 29 | ||
| Loss before income taxes | -1,271,749 | -910,065 | ||
| Provision for income taxes | 5,026 | 3,707 | ||
| Net loss | -1,276,775 | -913,772 | ||
| Basic net loss per share (in dollars per share) | -6.42 | -5.57 | ||
| Diluted net loss per share (in dollars per share) | -6.42 | -5.57 | ||
| Weighted average basic common shares outstanding (in shares) | 199,014,000 | 164,043,000 | ||
| Weighted average diluted common shares outstanding (in shares) | 199,014,000 | 164,043,000 | ||
INSMED Inc (INSM)
INSMED Inc (INSM)